Inventor · disambiguated record
Meike Hutt
Also filed as: HUTT MEIKE
10 granted patents·10 pending applications·41 citations·filing 2012–2025
86Inventor score
Top patents by PatentIndex Score
20 records- 0196US10618956B2Engineered T cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Apr 14, 2020·13 cites·16 claims
- 0294US10889645B2Engineered T cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Jan 12, 2021·3 cites·20 claims
- 0393US10428120B2Serum half-life extension using IgBDUNIV STUTTGART·Filed 2017·Granted Oct 1, 2019·19 cites·6 claims
- 0490US11840577B2Antigen binding proteins specifically binding MAGE-AIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Dec 12, 2023·2 cites·9 claims
- 0584US2024228611A1Novel engineered t cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2024·Application pending·0 cites
- 0683US12269881B2Antigen binding proteins specifically binding MAGE-AIMMATICS BIOTECHNOLOGIES GMBH·Filed 2023·Granted Apr 8, 2025·0 cites·8 claims
- 0779US11008402B2Antigen binding protein against HER3UNIV STUTTGART·Filed 2017·Granted May 18, 2021·3 cites·14 claims
- 0879US2024052054A1Antigen binding proteins specifically binding mage-aIMMATICS BIOTECHNOLOGIES GMBH·Filed 2023·Application pending·0 cites
- 0977US11859009B2Antigen binding proteins specifically binding PRAMEIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted Jan 2, 2024·0 cites·30 claims
- 1077US2024092933A1Antigen binding proteins specifically binding prameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2023·Application pending·0 cites
- 1175US11932689B2Engineered T cell receptors and immune therapy using the sameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Mar 19, 2024·0 cites·20 claims
- 1275US2023357428A1Antigen binding proteins specifically binding prameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2023·Application pending·0 cites
- 1370US2025215084A1Antigen binding proteins specifically binding mage-aIMMATICS BIOTECHNOLOGIES GMBH·Filed 2025·Application pending·0 cites
- 1469US10428149B2Single-chain tumor necrosis factor (TNF) ligand family molecules, fusion proteins and derivatives thereofUNIV STUTTGART·Filed 2016·Granted Oct 1, 2019·1 cites·23 claims
- 1568US2023203200A1Recruiting agent further binding an mhc moleculeIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Application pending·0 cites
- 1666US2025034227A1Antigen binding proteins against mageb2IMMATICS BIOTECHNOLOGIES GMBH·Filed 2024·Application pending·0 cites
- 1758US2021032370A1Recruiting agent further binding an mhc moleculeIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Application pending·0 cites
- 1852US12480958B2Method for the characterization of peptide:MHC binding polypeptidesIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Nov 25, 2025·0 cites·22 claims
- 1948US2023132241A1Antigen binding proteins specifically binding prameIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Application pending·0 cites
- 2047US2014220017A1Serum half-life extension using igbdUNIV STUTTGART·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Meike Hutt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →